What is the recommended dose of dexamethasone (corticosteroid) for pediatric croup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dexamethasone Dose for Pediatric Croup

Administer a single dose of dexamethasone 0.6 mg/kg (maximum 16 mg) orally, intramuscularly, or intravenously for children with croup. 1

Standard Dosing Protocol

  • The American Academy of Pediatrics recommends 0.6 mg/kg as the standard dose (maximum 16 mg), which can be given via oral, intramuscular, or intravenous routes. 1
  • All three routes of administration are equally effective, but oral administration is preferred when the child can tolerate it, as it avoids the pain of injection. 1
  • The maximum dose is capped at 16 mg regardless of weight—for example, a 38 kg child would receive 16 mg rather than the calculated 22.8 mg. 1

Evidence for Lower Dose Consideration

While 0.6 mg/kg remains the guideline-recommended dose, there is substantial research evidence supporting lower doses:

  • Multiple high-quality RCTs demonstrate that 0.15 mg/kg dexamethasone is equally effective as 0.6 mg/kg for treating croup. 2, 3
  • A 1995 study of 120 hospitalized children found no difference in duration of hospitalization, croup score reduction, or need for epinephrine between 0.15 mg/kg, 0.3 mg/kg, and 0.6 mg/kg doses. 2
  • A 2007 RCT in children with moderate to severe croup showed equivalent effectiveness between 0.15 mg/kg and 0.6 mg/kg, with median time to clinical improvement of approximately 8 hours in both groups. 3
  • The 2023 Cochrane review concluded that 0.15 mg/kg may be as effective as 0.60 mg/kg, though more RCTs are needed to strengthen this evidence. 4

However, given that current AAP guidelines explicitly recommend 0.6 mg/kg, this remains the standard of care in clinical practice. 1

Onset and Duration of Action

  • Clinical benefit begins as early as 30 minutes after administration, with statistically significant improvement evident by 30 minutes when using 0.15 mg/kg. 1, 5
  • Duration of action is approximately 24-72 hours, providing sustained symptom relief. 1
  • The single-dose regimen does not require tapering and does not cause significant adrenal suppression. 1

Adjunctive Therapy for Severe Cases

  • For moderate to severe croup with significant respiratory distress, add nebulized epinephrine (0.5 mL/kg of 1:1000 solution, maximum 5 mL) while waiting for dexamethasone to take effect. 1, 6
  • Epinephrine provides immediate but short-term symptom improvement (lasting approximately 2 hours), while dexamethasone provides longer-lasting relief. 1, 7
  • If racemic epinephrine is unavailable, L-epinephrine (1:1000) can be substituted at the same dosage. 6
  • Monitor patients for at least 2 hours after epinephrine administration for potential rebound airway obstruction. 7

Important Clinical Pitfalls

  • Do not use nebulized corticosteroids from hand-held inhalers with spacers—they are ineffective for croup. 1
  • Nebulized budesonide is equally effective as oral dexamethasone but is less practical in most clinical settings. 1
  • Lower doses than 0.6 mg/kg have historically been considered ineffective in older literature, though more recent evidence challenges this. 7
  • The onset of action is much earlier than the 4-6 hours previously suggested by older reviews—expect benefit by 30 minutes to 2 hours. 5, 4

References

Guideline

Duration of Action of Dexamethasone in Croup

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Glucocorticoids for croup in children.

The Cochrane database of systematic reviews, 2023

Guideline

Dexamethasone Treatment for Croup in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Croup.

The Journal of family practice, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.